It is an exciting period for the clinical management of multiple sclerosis (MS), with an expanding treatment landscape and recent approval of new disease-modifying therapies (DMTs) for both relapsing and progressive MS. A 2019 well-renowned annual MS meeting featured the latest information on cutting-edge research findings, clinical advances in the diagnosis and management of MS, and emerging care issues, as well as new MS practice trends, innovative care practices, and health policy issues affecting access to care.

However, while annual meetings are avenues for the release of emerging data, community clinicians are often unable to attend due to busy schedules and patient loads. As it is critical that neurologists involved in the care of patients with MS learn how to evaluate and apply the latest advances, CME Outfitters presents a 3-part series of podcasts that will examine and translate the emerging data to practice.

CMEOCast: Biomarkers for Diagnosis and Prognosis in MS


Participate Now

In Part 1 of this CMEOCast series, Dr. Aaron Miller identifies and presents the most important information on diagnostic modalities and biomarkers as tools to guide clinical decision-making.

CMEOCast: Navigating Current and Emerging MS Therapies – What Does the Evidence Say?


Participate Now

In the second episode of this MS CMEOCast series, Dr. Miller will cultivate the latest evidence on the safety and efficacy of current and emerging therapies for relapsing and progressive MS that was presented at a 2019 well-renowned annual MS meeting, with a goal of translating these findings to treatment decisions that optimize the care of patients with MS.

CMEOCast: Translating Evidence into an Individualized Treatment Plan in Patients with MS


Participate Now

CME Outfitters presents the final episode of the MS CMEOCast series from a 2019 well-renowned annual MS meeting, highlighting the latest clinical evidence supporting individualized strategies for treatment selection and switching.​